Development of human papillomavirus chimaeric L1/L2 candidate vaccines (Q43493362)

24 November 2017

Development of human papillomavirus chimaeric L1/L2 candidate vaccines (English)

1 reference

24 November 2017

5

1 reference

24 November 2017

Marieta McGrath

1

1 reference

24 November 2017

Gillian K de Villiers

series ordinal

2

1 reference

24 November 2017

Enid Shephard

series ordinal

3

1 reference

24 November 2017

Inga I Hitzeroth

series ordinal

4

1 reference

24 November 2017

1 May 2013

1 reference

24 November 2017

1 reference

24 November 2017

158

1 reference

24 November 2017

10

1 reference

24 November 2017

2079-2088

1 reference

https://scigraph.springernature.com/pub.10.1007/s00705-013-1713-8

24 November 2017

0 references

cites work

Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Arrangement of L2 within the papillomavirus capsid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Detection of protein aggregates, but not virus-like particles, when the major (L1) coat protein of a wild-type human papillomavirus type 16 (HPV-16) is expressed in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Natural history and epidemiology of HPV infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Human papillomavirus and HPV vaccines: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Protective immunity to rabbit oral and cutaneous papillomaviruses by immunization with short peptides of L2, the minor capsid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Differences in the post-translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

A protective and broadly cross-neutralizing epitope of human papillomavirus L2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

The future of vaccines for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Immunological consequences of using three different clinical/laboratory techniques of emulsifying peptide-based vaccines in incomplete Freund's adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Human papillomavirus type 16 L1 capsomeres induce L1-specific cytotoxic T lymphocytes and tumor regression in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Human dendritic cells are activated by chimeric human papillomavirus type-16 virus-like particles and induce epitope-specific human T cell responses in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Analysis of modified human papillomavirus type 16 L1 capsomeres: the ability to assemble into larger particles correlates with higher immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Enhanced papillomavirus-like particle production in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

GARDASIL: prophylactic human papillomavirus vaccine development--from bench top to bed-side

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

A direct comparison of human papillomavirus type 16 L1 particles reveals a lower immunogenicity of capsomeres than viruslike particles with respect to the induced antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

Broad-Spectrum Human Papillomavirus Vaccines: New Horizons but One Step at a Time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00705-013-1713-8

10.1007/S00705-013-1713-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

24 November 2017

0 references

1 reference